Recognising the importance of the US market, we opened business offices in Silicon Valley and New York in 2014.
With a team drawn from the UK and Germany with extensive experience across M&A, international expansion, commercial arrangements and data protection & privacy, we offer advice to some of the largest international tech and life sciences corporations. Additionally, each year, we assist between 50 to 75 North American growth companies on their global expansion plans.
While we don't practice US law, our team on the ground in the US works closely with Taylor Wessing lawyers from across the globe to support start-ups, scale-ups and multinational corporations on their expansion, M&A, capital raises and commercial needs throughout Europe, the Middle East and Asia.
Tools and online services
International expansion guide
Our international expansion guide is designed to steer and support companies looking to expand internationally in multiple jurisdictions. The aim of the guide is to provide high level information on some frequently asked questions across the range of legal topics companies typically ask us when looking to launch in a new market.
MDR Medical Device Checker
Our MDR Medical Device Checker assesses the likelihood of your product falling within the scope of the Medical Devices Regulation.
International M&A checklist
Our checklist is designed to provide support and high-level information to companies considering undertaking an M&A transaction in multiple global jurisdictions.
Guides for overseas investors looking to invest in the UK and the Netherlands.
Play: our guide to the video games industry
The 4th edition of the Taylor Wessing Play Guide is an overview of our long-held expertise in the games industry and our experience as thought leaders across the sector.
Latest news & insights
Incoming EU data and digital legislation
There's a lot going on in the data and digital space in terms of incoming EU legislation. Here is a summary of key proposals which will impact the use of data (personal and non-personal) and likely timelines, as at 10 May 2022.
by multiple authors